This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2001 Jun;34(6):964-5.

doi: 10.1016/s0168-8278(01)00022-8.

Ulcerative colitis associated with interferon treatment for chronic hepatitis C

C Mavrogiannis, I S Papanikolaou, I S Elefsiniotis, D I Psilopoulos, A Karameris, G Karvountzis

PMID: 11451187
DOI: 10.1016/s0168-8278(01)00022-8

Case Reports

Ulcerative colitis associated with interferon treatment for chronic hepatitis C

C Mavrogiannis et al. J Hepatol. 2001 Jun.

. 2001 Jun;34(6):964-5.

doi: 10.1016/s0168-8278(01)00022-8.

Authors

C Mavrogiannis, I S Papanikolaou, I S Elefsiniotis, D I Psilopoulos, A Karameris, G Karvountzis

PMID: 11451187
DOI: 10.1016/s0168-8278(01)00022-8

No abstract available

PubMed Disclaimer

Similar articles

[Ulcerative colitis. When is standard therapy enough?].
Stange EF. Stange EF. MMW Fortschr Med. 2000 Oct 12;142(41):39-40. MMW Fortschr Med. 2000. PMID: 11085075 German. No abstract available.
Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.
Sprenger R, Sagmeister M, Offner F. Sprenger R, et al. Gut. 2005 Mar;54(3):438-9; author reply 439. doi: 10.1136/gut.2004.049940. Gut. 2005. PMID: 15710996 Free PMC article. No abstract available.
[Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa].
Napoli N, Tortorella C, Deramo MT, Antonaci A, Parisi CV, Antonaci S. Napoli N, et al. Recenti Prog Med. 2004 Nov;95(11):525-8. Recenti Prog Med. 2004. PMID: 15598090 Italian.
[For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
[No authors listed] [No authors listed] MMW Fortschr Med. 2009 May 7;151(19):38-9. MMW Fortschr Med. 2009. PMID: 19827443 Review. German. No abstract available.
[A case of ulcerative colitis along with characteristic features on computed tomography (CT), developed by the treatment with interferon for chronic hepatitis C].
Niki T, Nishida K, Honsako Y, Matsumura Y, Ueno H, Fujimi T, Sashikata T. Niki T, et al. Nihon Shokakibyo Gakkai Zasshi. 2001 Apr;98(4):399-404. Nihon Shokakibyo Gakkai Zasshi. 2001. PMID: 11400269 Review. Japanese. No abstract available.

See all similar articles

Cited by

Secondary causes of inflammatory bowel diseases.
Ghouri YA, Tahan V, Shen B. Ghouri YA, et al. World J Gastroenterol. 2020 Jul 28;26(28):3998-4017. doi: 10.3748/wjg.v26.i28.3998. World J Gastroenterol. 2020. PMID: 32821067 Free PMC article. Review.
Adminstration of PEG-Interferon to a Patient with Ulcerative Colitis and Chronic Hepatitis C Correlated with Reduced Colonic Inflammation and Reversal of Peripheral Th1/Th2 Ratios.
Kasahara K, Nakase H, Uza N, Ueno S, Matsuura M, Mikami S, Inoue S, Chiba T. Kasahara K, et al. Case Rep Gastroenterol. 2007 Dec 21;1(1):157-61. doi: 10.1159/000112654. Case Rep Gastroenterol. 2007. PMID: 21487562 Free PMC article.
Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma.
Saha S, Jing X, Park SY, Wang S, Li X, Gupta D, Dziarski R. Saha S, et al. Cell Host Microbe. 2010 Aug 19;8(2):147-62. doi: 10.1016/j.chom.2010.07.005. Cell Host Microbe. 2010. PMID: 20709292 Free PMC article.
Type-I interferons in atherosclerosis.
Chen HJ, Tas SW, de Winther MPJ. Chen HJ, et al. J Exp Med. 2020 Jan 6;217(1):e20190459. doi: 10.1084/jem.20190459. J Exp Med. 2020. PMID: 31821440 Free PMC article. Review.
Interferon-α increases monocyte migration via platelet-monocyte interaction in murine intestinal microvessels.
Higashiyama M, Hokari R, Kurihara C, Ueda T, Nakamura M, Komoto S, Okada Y, Watanabe C, Kawaguchi A, Nagao S, Miura S. Higashiyama M, et al. Clin Exp Immunol. 2010 Oct;162(1):156-62. doi: 10.1111/j.1365-2249.2010.04222.x. Epub 2010 Aug 19. Clin Exp Immunol. 2010. PMID: 20659125 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information